Dr. Trevejo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Kendall Square
B3301
Cambridge, MA 02139Phone+1 617-401-2017- Is this information wrong?
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 2004 - 2008
- Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2005
- Weill Cornell MedicineClass of 2002
Certifications & Licensure
- MA State Medical License 2004 - 2024
Clinical Trials
- A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus Start of enrollment: 2012 Mar 01
Publications & Presentations
PubMed
- 83 citationsImplications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures.Nikolai Eroshenko, Taylor Gill, Marianna K Keaveney, George M. Church, Jose M Trevejo, Hannu Rajaniemi> ;Nature Biotechnology. 2020 Jul 1
- 55 citationsSafety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-control...Ellie Hershberger, Susan Sloan, Kristin Narayan, Catherine A. Hay, Patrick F. Smith, Frank Engler, Rienk E. Jeeninga, Saskia Smits, Jose M. Trevejo, Zach Shriver, Davi...> ;Ebiomedicine. 2019 Feb 1
- 41 citationsPimodivir treatment in adult volunteers experimentally inoculated with live influenza virus: a Phase IIa, randomized, double-blind, placebo-controlled study.Jose M Trevejo, Mohammed Asmal, Johan Vingerhoets, Ramon Polo, Sarah Robertson, Ying Jiang, Tara L. Kieffer, Lorant Leopold> ;Antiviral Therapy. 2017 May 1
- Join now to see all
Press Mentions
- Rocket Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent ProgressMay 10th, 2021
- Sorrento Enters into Merger Agreement to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Starting with Neutralizing Antibodies to Treat COVID-19 and Cancer TherapeuticsAugust 20th, 2020
- Visterra Announces Publication of Clinical Data on VIS410 in the Journal EBioMedicineFebruary 26th, 2016
Hospital Affiliations
- Beth Israel Deaconess Medical CenterBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: